9 trends tracked about this subject — the full history, oldest to newest below.
Pharmacists and health experts are urging GLP-1 weight loss medication users to prioritize specific nutritional strategies to mitigate side effects.
New research suggests a link between GLP-1 weight-loss medications and an increased risk of hair loss, though the occurrence is described as rare.
New research links GLP-1 weight-loss medications like Ozempic and Mounjaro to an increased risk of hair loss in patients.
Novo Nordisk has filed a lawsuit against Eli Lilly over allegations of deceptive and misleading advertising regarding GLP-1 weight-loss drugs.
Emerging research suggests GLP-1 receptor agonists may provide a promising treatment for binge eating disorder and emotional eating symptoms.
GLP-1 weight‑loss drugs spark a wave of research, clinical guidance and market buzz as they expand beyond obesity treatment.
11 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New study data indicates that GLP-1 weight loss medications are associated with a significant reduction in the risk of developing four specific cancer types.
New research indicates that patients taking GLP-1 weight loss drugs are reducing their physical activity levels.